Charles Schwab’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
177,937
+7,322
+4% +$416K ﹤0.01% 2061
2026
Q1
$11M Sell
170,615
-6,415
-4% -$585K ﹤0.01% 2052
2025
Q4
$23M Buy
177,030
+527
+0.3% +$72.3K ﹤0.01% 1662
2025
Q3
$19M Buy
176,503
+8,900
+5% +$970K ﹤0.01% 1764
2025
Q2
$15.5M Buy
167,603
+20,696
+14% +$1.62M ﹤0.01% 1799
2025
Q1
$13M Sell
146,907
-4,496
-3% -$390K ﹤0.01% 1834
2024
Q4
$11.6M Buy
151,403
+4,369
+3% +$305K ﹤0.01% 1950
2024
Q3
$6.24M Buy
147,034
+110,666
+304% +$3.74M ﹤0.01% 2258
2024
Q2
$951K Buy
+36,368
New +$689K ﹤0.01% 2956
2023
Q3
Sell
-95,189
Closed -$567K 3632
2023
Q2
$567K Sell
95,189
-15,631
-14% -$124K ﹤0.01% 2992
2023
Q1
$1.33M Buy
110,820
+65,645
+145% +$875K ﹤0.01% 2635
2022
Q4
$393K Sell
45,175
-6,799
-13% -$150K ﹤0.01% 3059
2022
Q3
$1.51M Buy
51,974
+2,300
+5% +$105K ﹤0.01% 2662
2022
Q2
$2.07M Buy
49,674
+30,695
+162% +$2.08M ﹤0.01% 2560
2022
Q1
$1.92M Buy
18,979
+471
+3% +$52.4K ﹤0.01% 2661
2021
Q4
$2.72M Buy
18,508
+226
+1% +$50.5K ﹤0.01% 2598
2021
Q3
$4.58M Buy
+18,282
New +$6.28M ﹤0.01% 2419

Other funds holding WGS

Charles Schwab's WGS Position: Q2 2026 in Review

Charles Schwab increased its GeneDx Holdings (WGS) stake by 4.3% in Q2 2026, buying an estimated $416K and bringing the position to 177,937 shares worth $12.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

Charles Schwab first reported a position in WGS in Q3 2021 and has held it in 17 quarters since. The position peaked at $23M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Charles Schwab held 177,937 shares of GeneDx Holdings worth $12.2M as of Q2 2026.
  • Charles Schwab bought 7,322 GeneDx Holdings shares in Q2 2026, an estimated $416K.
  • GeneDx Holdings made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2061 holding.
  • Charles Schwab first reported a position in GeneDx Holdings in Q3 2021 and has held it in 17 quarters since.
  • Charles Schwab's GeneDx Holdings position peaked at $23M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.